Grafa News and Videos — Page 664

Aeries Technology (NASDAQ:AERT) announced its financial results for the fiscal year ended March 31, 2026, marking a pivotal year of transformation.

AstroNova (NASDAQ:ALOT), a global leader in specialized print technology solutions, reported financial results for its fiscal 2027 first quarter ended April 30, 2026.

Lyell Immunopharma (NASDAQ:LYEL) announced on Monday that it has amended its ongoing U.S. Phase 1 clinical trial for LYL273 to a Phase 1/2 design.

Shattuck Labs (NASDAQ:STTK) announced positive top-line results from its Phase 1 clinical trial of SL-325, a novel Death Receptor 3 (DR3) blocking antibody.

Honeywell International (NASDAQ:HON) announced on Monday that it is reaffirming its full-year 2026 financial guidance as the company nears the final stages of its portfolio transformation.

Gamehaus Holdings (NASDAQ:GMHS) reported its unaudited financial results for the third quarter of fiscal year 2026, ended March 31, 2026.

American Battery Technology Company (NASDAQ:ABAT) announced today that it has successfully won its appeal with the U.S. Department of Energy (DOE) regarding the reinstatement of a competitive grant award.

Duluth Holdings (NASDAQ:DLTH) reported financial results for the first quarter of fiscal 2026, ended May 3, 2026, highlighting significant progress in operational efficiency despite a challenging retail environment.

Advanced Micro Devices (NASDAQ:AMD) announced plans to invest up to £2 billion in the United Kingdom over the next five years, a strategic move designed to accelerate AI innovation, scientific research, and technical workforce development.

Alvotech (NASDAQ:ALVO) announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio (vedolizumab) for intravenous administration.